Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 6, 2012, Pages 598-603

  Jacobi, Christina ^a   Kruse, Friedrich E ^a   Cursiefen, Claus ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; EYE DROPS; PRESERVATIVE FREE HYDROXYPROPYL GUAR; PRESERVATIVE FREE TAMARINDUS INDICA SEED POLYSACCHARIDE; SYSTANE UD; UNCLASSIFIED DRUG; VISINE INTENSIV 1% EDO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRY EYE; FEMALE; HUMAN; KERATOCONJUNCTIVITIS SICCA; MALE; OCULAR SURFACE DISEASE INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADMINISTRATION, OPHTHALMIC; ADULT; FEMALE; HUMANS; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; POLYSACCHARIDES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEEDS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TAMARINDUS; TEARS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869440742     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0066     Document Type: Article

References (40)

1. Lemp, M.A., Baudouin, C., Baum, J., et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocul. Surf. 5:75-92, 2007. (Pubitemid 351902651)
2. Jacobi, C., Dietrich, T., Cursiefen, C., et al. The dry eye. Current concepts on classification, diagnostics, and pathogenesis. Ophthalmologe. 103:9-17, 2006. (Pubitemid 43170301)
3. Jacobi, C., Wenkel, H., Jacobi, A., et al. Hepatitis C and ocular surface disease. Am. J. Ophthalmol. 144:705-711, 2007.
4. Baudouin, C. The pathology of dry eye. Surv. Ophthalmol. 45: 211-220, 2001.
5. Stern, M.E., and Pflugfelder, S.C. Inflammation in dry eye. Ocul. Surf. 2:124-130, 2004. (Pubitemid 41263879)
6. Khanal, S., Tomlinson, A., and Diaper, C.J. Tear physiology of aqueous deficiency and evaporative dry eye. Optom. Vis. Sci. 86:1235-1240, 2009.
7. Lemp, M.A. Evaluation and differential diagnosis of keratoconjunctivitis sicca. J. Rheumatol. Suppl. 61:11-14, 2000.
8. Barabino, S., Montaldo, E., Solignani, F., et al. Immune response in the conjunctival epithelium of patients with dry eye. Exp. Eye Res. 91:524-529, 2010.
9. Jacobi, C., Jacobi, A., Kruse, F.E., et al. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea. 30:1289-1292, 2011.
10. Gidley, M.J., Lillford, P.J., Rowlands, D.W., et al. Structure and solution properties of tamarind-seed polysaccharide. Carbohydr. Res. 214:299-314, 1991.
11. Burgalassi, S., Raimondi, L., Pirisino, R., et al. Effect of xyloglucan (tamarind seed polysaccharide) on conjunctival cell adhesion to laminin and on corneal epithelium wound healing. Eur. J. Ophthalmol. 10:71-76, 2000. (Pubitemid 30191108)
12. Komutarin, T., Azadi, S., Butterworth, L., et al. Extract of the seed coat of Tamarindus indica inhibits nitric oxide production by murine macrophages in vitro and in vivo. Food Chem. Toxicol. 42:649-658, 2004. (Pubitemid 38314837)
13. Uccello-Barretta, G., Nazzi, S., Balzano, F., et al. Enhanced affinity of ketotifen toward tamarind seed polysaccharide in comparison with hydroxyethylcellulose and hyaluronic acid: a nuclear magnetic resonance investigation. Bioorg. Med. Chem. 16:7371-7376, 2008.
14. Rolando, M., and Valente, C. Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study. BMC Ophthalmol. 7:5, 2007.
15. Wang, T.J., Wang, I.J., Ho, J.D., et al. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, openlabel, randomized, parallel-group, noninferiority study. Clin. Ther. 32:44-52, 2010.
16. Rolando, M., Autori, S., Badino, F., et al. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J. Ocul. Pharmacol. Ther. 25:271-278, 2009.
17. Uccello-Barretta, G., Nazzi, S., Zambito, Y., et al. Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops. Int. J. Pharm. 395:122-131, 2010.
18. Petricek, I., Berta, A., Higazy, M.T., et al. Hydroxypropylguar gellable lubricant eye drops for dry eye treatment. Expert Opin. Pharmacother. 9:1431-1436, 2008. (Pubitemid 351877526)
19. Schiffman, R.M., Christianson, M.D., Jacobsen, G., et al. Reliability and validity of the Ocular Surface Disease Index. Arch. Ophthalmol. 118:615-621, 2000. (Pubitemid 30327337)
20. Hö h, H., Schirra, F., Kienecker, C., et al. Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye. Ophthalmologe. 92:802-808, 1995. (Pubitemid 26027999)
21. Tomlinson, A., and Khanal, S. Assessment of tear film dynamics: quantification approach. Ocul. Surf. 3:81-95, 2005. (Pubitemid 40775110)
22. Lemp, M.A., and Hamil, J.R., Jr. Factors affecting tear film breakup in normal eyes. Arch. Ophthalmol. 89:103-105, 1973.
23. Ousler, G.W., Michaelson, C., and Christensen, M.T. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea. 26:949-952, 2007. (Pubitemid 47329799)
24. Chen, Z., Tong, L., Li, Z., et al. Hyperosmolarity-induced cornification of human corneal epithelial cells is regulated by JNK MAPK. Invest. Ophthalmol. Vis. Sci. 49:539-549, 2008.
25. Kinoshita, S., Kiorpes, T.C., Friend, J., et al. Goblet cell density in ocular surface disease: a better indicator than tear mucin. Arch. Ophthalmol. 101:1284-1287, 1983. (Pubitemid 13030951)
26. Tsubota, K., and Yamada, M. Tear evaporation from the ocular surface. Invest. Ophthalmol. Vis. Sci. 33:2942-2950, 1992.
27. Pflugfelder, S.C., Tseng, S.C., Sanabria, O., et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 17:38-56, 1998. (Pubitemid 28047008)
28. Goto, E., Endo, K., Suzuki, A., et al. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest. Ophthalmol. Vis. Sci. 44:533-539, 2003. (Pubitemid 36159696)
29. Bron, A.J., Tiffany, J.M., Gouveia, S.M., et al. Functional aspects of the tear film lipid layer. Exp. Eye Res. 78:347-360, 2004. (Pubitemid 38183311)
30. Goto, E., Yagi, Y., Matsumoto, Y., et al. Impaired functional visual acuity of patients with dry eye. Am. J. Ophthalmol. 133:181-186, 2002. (Pubitemid 34072045)
31. Yokoi, N., and Komuro, A. Non-invasive methods of assessing the tear film. Exp. Eye Res. 78:399-407, 2004. (Pubitemid 38183318)
32. Guzey, M., Satici, A., Karaman, S.K., et al. The effect of lubricating eye drop containing hydroxypropyl guar on perimetry results of patients with glaucoma and trachomatous dry eye. Ophthalmologica. 224:109-115, 2010.
33. Uchiyama, E., Di Pascuale, M.A., Butovich, I.A. et al. Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar. Eye Contact Lens. 34:331- 334, 2008.
34. Versura, P., Profazio, V., and Campos, E.C. One month use of Systane improves ocular surface parameters in subjects with moderate symptoms of ocular dryness. Clin. Ophthalmol. 2:629-635, 2008.
35. Sánchez, M.A., Arriola-Villalobos, P., et al. The effect of preservative-free HP-Guar on dry eye after phacoemulsification: a flow cytometric study. Eye. 24:1331-1337, 2010.
36. Springs, C.L. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye. Adv. Ther. 27:681-690, 2010.
37. Christensen, M.T. Corneal staining reductions observed after treatment with Systane lubricant eye drops. Adv. Ther. 25:1191-1199, 2008.
38. Hartsein, I., Khwarg, S., and Przydryga, J. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Curr. Med. Res. Opin. 21:255-260, 2005. (Pubitemid 40469901)
39. Christensen, M.T., Cohen, S., Rinehart, J., et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr. Eye Res. 28:55-62, 2004. (Pubitemid 38161174)
40. Di Colo, G., Zambito, Y., Zaino, C., et al. Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model. Drug Dev. Ind. Pharm. 35:941-949, 2009.